BLUE
bluebird bio
BLUE
BLUE
Delisted
BLUE was delisted on the 30th of May, 2025.
247 hedge funds and large institutions have $2.78B invested in bluebird bio in 2020 Q1 according to their latest regulatory filings, with 30 funds opening new positions, 96 increasing their positions, 75 reducing their positions, and 55 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
31% less call options, than puts
Call options by funds: $24.2M | Put options by funds: $35.1M
45% less first-time investments, than exits
New positions opened: 30 | Existing positions closed: 55
47% less capital invested
Capital invested by funds: $5.27B → $2.78B (-$2.49B)
Holders
247
Holding in Top 10
3
Calls
$24.2M
Puts
$35.1M
Top Buyers
| 1 | +$73.3M | |
| 2 | +$50.9M | |
| 3 | +$46.9M | |
| 4 |
PIM
Platinum Investment Management
Sydney Australia 2000,
Australia
|
+$20.8M |
| 5 |
AC
Armistice Capital
New York
|
+$14.3M |
Top Sellers
| 1 | -$112M | |
| 2 | -$42.6M | |
| 3 | -$30.2M | |
| 4 |
Capital International Investors
Los Angeles,
California
|
-$29.4M |
| 5 |
LGM
Logos Global Management
San Francisco,
California
|
-$17.9M |